Literature DB >> 27703621

Sugammadex: watch out for new side effects.

Yoon-Hee Kim1.   

Abstract

Entities:  

Year:  2016        PMID： 27703621      PMCID： PMC5047976          DOI： 10.4097/kjae.2016.69.5.427

Source DB:  PubMed          Journal:  Korean J Anesthesiol        ISSN： 2005-6419


× No keyword cloud information.
  14 in total

1.  Suspected unexpected adverse effect of sugammadex: hypotension.

Authors:  Merja Kokki; Mohamed Ali; Matti Turunen; Hannu Kokki
Journal:  Eur J Clin Pharmacol       Date:  2011-12-29       Impact factor: 2.953

2.  Safety and efficacy of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in cardiac patients undergoing noncardiac surgery.

Authors:  Vegard Dahl; Philippe E Pendeville; Markus W Hollmann; Tom Heier; Esther Am Abels; Manfred Blobner
Journal:  Eur J Anaesthesiol       Date:  2009-10       Impact factor: 4.330

Review 3.  Sugammadex: what do we know and what do we still need to know? A review of the recent (2013 to 2014) literature.

Authors:  T Ledowski
Journal:  Anaesth Intensive Care       Date:  2015-01       Impact factor: 1.669

Review 4.  Hypersensitivity associated with sugammadex administration: a systematic review.

Authors:  A Tsur; A Kalansky
Journal:  Anaesthesia       Date:  2014-05-22       Impact factor: 6.955

5.  Effects of sugammadex doses up to 32 mg/kg alone or in combination with rocuronium or vecuronium on QTc prolongation: a thorough QTc study.

Authors:  Pieter-Jan de Kam; Jacqueline van Kuijk; Marita Prohn; Torben Thomsen; Pierre Peeters
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

Review 6.  Histamine-induced coronary artery spasm: the concept of allergic angina.

Authors:  N G Kounis; G M Zavras
Journal:  Br J Clin Pract       Date:  1991

7.  Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial.

Authors:  Friedrich K Pühringer; Christopher Rex; Andreas W Sielenkämper; Casper Claudius; Per Bo Larsen; Martine E Prins; Matthias Eikermann; Karin S Khuenl-Brady
Journal:  Anesthesiology       Date:  2008-08       Impact factor: 7.892

8.  Negative pressure pulmonary edema after reversing rocuronium-induced neuromuscular blockade by sugammadex.

Authors:  Manzo Suzuki; Toshiichiro Inagi; Takehiko Kikutani; Takuya Mishima; Hiroyasu Bito
Journal:  Case Rep Anesthesiol       Date:  2014-02-13

9.  Discovery, development, and clinical application of sugammadex sodium, a selective relaxant binding agent.

Authors:  Mark Welliver; John McDonough; Nicholas Kalynych; Robert Redfern
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

10.  Sugammadex, a neuromuscular blockade reversal agent, causes neuronal apoptosis in primary cultures.

Authors:  José M Palanca; Diana Aguirre-Rueda; Manuel V Granell; Martin Aldasoro; Alma Garcia; Antonio Iradi; Elena Obrador; Maria Dolores Mauricio; Jose Vila; Anna Gil-Bisquert; Soraya L Valles
Journal:  Int J Med Sci       Date:  2013-08-03       Impact factor: 3.738
View more
  3 in total

1.  Severe Hypotension, Bradycardia and Asystole after Sugammadex Administration in an Elderly Patient.

Authors:  Carmen Fierro; Alessandro Medoro; Donatella Mignogna; Carola Porcile; Silvia Ciampi; Emanuele Foderà; Romeo Flocco; Claudio Russo; Gennaro Martucci
Journal:  Medicina (Kaunas)       Date:  2021-01-19       Impact factor: 2.430

2.  IN REPLY.

Authors:  Yong Jun Choi; Jeong Wook Park; Sang Hun Kim; Ki Tae Jung
Journal:  Anesth Pain Med (Seoul)       Date:  2020-01-31

3.  [Severe bradycardia and asystole associated with sugammadex: case report].

Authors:  Catarina Oliveira; Catarina Marques; Vânia Simões; Leina Spencer; Rita Poeira; Margarida Casteleira
Journal:  Braz J Anesthesiol       Date:  2018-10-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.